One of these is the so-called GLP-1 patch (sometimes called "Mounjaro patches")
and stock ownership in Gilead Sciences
Most reported side effects are mild
Speaking with MNT , Megan Warnke, RDN, a registered dietician nutritionist and Certified Diabetes Care and Education Specialist, also not involved in this research, explained that a very low-calorie diet is not viable approach beyond a short-term intervention: The key words in this study are short term results. Like with any diet, this approach may work for a short period of time, but its not sustainable for long term results. Also, appetite suppression from semaglutide can help patients follow a calorie-restricted diet, but other factors like stress, sleep, and food insecurity will also impact diet success, which is something this drug cant fix, Warnke explained
Long-term safety note: Ipamorelin was well-tolerated in its Phase II clinical trial at doses up to 0.03 mg/kg IV twice daily for up to 7 days (Beck et al., 2014)
/assets/images/provider/photos/2749086.jpeg)
